Cancer Research Annual Meeting 2010 EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 56, 21-26, January 1, 1996]
© 1996 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, K.-Y.
Right arrow Articles by Wu, T.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, K.-Y.
Right arrow Articles by Wu, T.-C.

Treatment of Established Tumors with a Novel Vaccine That Enhances Major Histocompatibility Class II Presentation of Tumor Antigen1

Ken-Yu Lin, Frank G. Guarnieri, Kevin F. Staveley-O'Carroll, Hyam I. Levitsky, J. Thomas August, Drew M. Pardoll and Tzyy-Choou Wu2

Departments of Pathology [K-Y. L., T-C. W.], Pharmacology and Molecular Science [F. G. G., J. T. A.], Surgery [K. F. S-O.], and Oncology [H. I. L., J. T. A., D. M. P.], The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-6417

Presentation of antigenic peptides by MHC class II molecules to CD4+ T cells is critical to the generation of antitumor immunity. In an attempt to enhance MHC class II antigen processing, we linked the sorting signals of the lysosome-associated membrane protein (LAMP-1) to the cytoplasmic/nuclear human papilloma virus (HPV-16) E7 antigen, creating a chimera (Sig/E7/LAMP-1). Previously, we found that expression of this chimera in vitro and in vivo with a recombinant vaccinia vector targeted E7 to endosomal and lysosomal compartments and enhanced MHC class II presentation to CD4+ T cells compared to vaccinia expressing wild-type E7. In the current study, we tested these recombinant vaccinia for in vivo protection against an E7+ tumor, TC-1, which was derived from primary epithelial cells of C57BL/6 mice cotransformed with HPV-16 E6 and E7 and c-Ha-ras oncogenes. All mice vaccinated with 1 x 107 plaque-forming units of wild-type E7-vaccinia showed progressive tumor growth when challenged with a tumorigenic dose of TC-1 tumor cells; in contrast, 80% of mice vaccinated with the chimeric Sig/E7/LAMP1 vaccinia remained tumor free 3 months after tumor injection. Furthermore, treatment with the Sig/E7/LAMP-1 vaccinia vaccine cured mice with small established TC-1 tumors, whereas the wild-type E7-vaccinia showed no effect on this established tumor burden. These findings point out the therapeutic limitations of recombinant vaccinia expressing unmodified tumor antigens. Further, they demonstrate that modifications that reroute a cytosolic tumor antigen to the endosomal/lysosomal compartment can profoundly improve the in vivo therapeutic potency of recombinant vaccines.

1 This work was supported by NIH Grants 5 PO1 34582-01 and P50 CA62924, and by a gift from Mr. and Mrs. Zandy Leaderman. F. G. G. was supported by the Gustavus and Louise Pfeiffer Research Foundation.

2 To whom requests for reprints should be addressed, at Department of Pathology, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287. Phone: (410) 614-3899; Fax: (410) 614-3548.

Received 10/27/95. Accepted 11/22/95.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
K. A. Smith, B. L. Meisenburg, V. L. Tam, R. R. Pagarigan, R. Wong, D. K. Joea, L. Lantzy, M. A. Carrillo, T. M. Gross, U. M. Malyankar, et al.
Lymph Node-Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus-Transformed Tumors
Clin. Cancer Res., October 1, 2009; 15(19): 6167 - 6176.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. C. Crisanti, A. F. Wallace, V. Kapoor, F. Vandermeers, M. L. Dowling, L. P. Pereira, K. Coleman, B. G. Campling, Z. G. Fridlender, G. D. Kao, et al.
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
Mol. Cancer Ther., August 1, 2009; 8(8): 2221 - 2231.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C.-M. Chuang, A. Monie, A. Wu, S. I. Pai, and C.-F. Hung
Combination of Viral Oncolysis and Tumor-Specific Immunity to Control Established Tumors
Clin. Cancer Res., July 15, 2009; 15(14): 4581 - 4588.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Dibra, J. J. Cutrera, X. Xia, M. P. Birkenbach, and S. Li
Expression of WSX1 in Tumors Sensitizes IL-27 Signaling-Independent Natural Killer Cell Surveillance
Cancer Res., July 1, 2009; 69(13): 5505 - 5513.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. P. Lepique, K. R. P. Daghastanli, I. M. Cuccovia, and L. L. Villa
HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses
Clin. Cancer Res., July 1, 2009; 15(13): 4391 - 4400.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Gu, M. Cochrane, G. R. Leggatt, E. Payne, A. Choyce, F. Zhou, R. Tindle, and N. A. J. McMillan
Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses
PNAS, May 19, 2009; 106(20): 8314 - 8319.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Bousarghin, A. Touze, G. Gaud, S. Iochmann, E. Alvarez, P. Reverdiau, J. Gaitan, M.-L. Jourdan, P.-Y. Sizaret, and P. L. Coursaget
Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs
Mol. Cancer Ther., February 1, 2009; 8(2): 357 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. Radkevich-Brown, J. Jacob, M. Kershaw, and W.-Z. Wei
Genetic Regulation of the Response to Her-2 DNA Vaccination in Human Her-2 Transgenic Mice
Cancer Res., January 1, 2009; 69(1): 212 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Kim, G. Buchlis, Z. G. Fridlender, J. Sun, V. Kapoor, G. Cheng, A. Haas, H. K. Cheung, X. Zhang, M. Corbley, et al.
Systemic Blockade of Transforming Growth Factor-{beta} Signaling Augments the Efficacy of Immunogene Therapy
Cancer Res., December 15, 2008; 68(24): 10247 - 10256.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Kim, T. Hoory, A. Monie, J. P.-Y. Ting, C.-F. Hung, and T.-C. Wu
Enhancement of DNA Vaccine Potency through Coadministration of CIITA DNA with DNA Vaccines via Gene Gun
J. Immunol., May 15, 2008; 180(10): 7019 - 7027.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C.-W. Tseng, C.-F. Hung, R. D. Alvarez, C. Trimble, W. K. Huh, D. Kim, C.-M. Chuang, C.-T. Lin, Y.-C. Tsai, L. He, et al.
Pretreatment with Cisplatin Enhances E7-Specific CD8+ T-Cell-Mediated Antitumor Immunity Induced by DNA Vaccination
Clin. Cancer Res., May 15, 2008; 14(10): 3185 - 3192.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
J. B. Liao, J. Publicover, J. K. Rose, and D. DiMaio
Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 Protein
Clin. Vaccine Immunol., May 1, 2008; 15(5): 817 - 824.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Bian, Y. Wang, Z. Lu, Z. Ye, L. Zhao, J. Ren, H. Zhang, L. Ruan, and H. Tian
Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice
Mol. Cancer Ther., May 1, 2008; 7(5): 1329 - 1335.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. F. Setiadi, M. D. David, R. P. Seipp, J. A. Hartikainen, R. Gopaul, and W. A. Jefferies
Epigenetic Control of the Immune Escape Mechanisms in Malignant Carcinomas
Mol. Cell. Biol., November 15, 2007; 27(22): 7886 - 7894.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-L. Chang, Y.-C. Tsai, L. He, T.-C. Wu, and C.-F. Hung
Cancer Immunotherapy Using Irradiated Tumor Cells Secreting Heat Shock Protein 70
Cancer Res., October 15, 2007; 67(20): 10047 - 10057.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Berraondo, C. Nouze, X. Preville, D. Ladant, and C. Leclerc
Eradication of Large Tumors in Mice by a Tritherapy Targeting the Innate, Adaptive, and Regulatory Components of the Immune System
Cancer Res., September 15, 2007; 67(18): 8847 - 8855.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
H. Liu, B. H. Wu, G. J. Rowse, and P. C. R. Emtage
Induction of CD4-Independent E7-Specific CD8+ Memory Response by Heat Shock Fusion Protein
Clin. Vaccine Immunol., August 1, 2007; 14(8): 1013 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. B. Jacob, Y.-c. M. Kong, C. Meroueh, D. P. Snower, C. S. David, Y.-S. Ho, and W.-Z. Wei
Control of Her-2 Tumor Immunity and Thyroid Autoimmunity by MHC and Regulatory T Cells
Cancer Res., July 15, 2007; 67(14): 7020 - 7027.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. W. Kim, T. Y. Lee, H. C. Bae, J. H. Hahm, Y. H. Kim, C. Park, T. H. Kang, C. J. Kim, M. H. Sung, and H. Poo
Oral Administration of High Molecular Mass Poly-{gamma}-Glutamate Induces NK Cell-Mediated Antitumor Immunity
J. Immunol., July 15, 2007; 179(2): 775 - 780.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T-C. Wu
The Role of Vascular Cell Adhesion Molecule-1 in Tumor Immune Evasion
Cancer Res., July 1, 2007; 67(13): 6003 - 6006.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. N. Kochenderfer, J. L. Simpson, C. D. Chien, and R. E. Gress
Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT
Blood, July 1, 2007; 110(1): 450 - 460.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
A. C. Hoover, W. C. Spanos, G. F. Harris, M. E. Anderson, A. J. Klingelhutz, and J. H. Lee
The Role of Human Papillomavirus 16 E6 in Anchorage-Independent and Invasive Growth of Mouse Tonsil Epithelium
Arch Otolaryngol Head Neck Surg, May 1, 2007; 133(5): 495 - 502.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Loeser, K. Loser, M. S. Bijker, M. Rangachari, S. H. van der Burg, T. Wada, S. Beissert, C. J.M. Melief, and J. M. Penninger
Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells
J. Exp. Med., April 16, 2007; 204(4): 879 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K.-Y. Lin, D. Lu, C.-F. Hung, S. Peng, L. Huang, C. Jie, F. Murillo, J. Rowley, Y.-C. Tsai, L. He, et al.
Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune Evasion
Cancer Res., February 15, 2007; 67(4): 1832 - 1841.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. H. Kang, J. H. Lee, C. K. Song, H. D. Han, B. C. Shin, S. I. Pai, C.-F. Hung, C. Trimble, J.-S. Lim, T. W. Kim, et al.
Epigallocatechin-3-Gallate Enhances CD8+ T Cell-Mediated Antitumor Immunity Induced by DNA Vaccination
Cancer Res., January 15, 2007; 67(2): 802 - 811.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. H. Bae, Y.-J. Park, J.-B. Park, Y. S. Choi, M. S. Kim, and J.-I. Sin
Therapeutic Synergy of Human Papillomavirus E7 Subunit Vaccines plus Cisplatin in an Animal Tumor Model: Causal Involvement of Increased Sensitivity of Cisplatin-Treated Tumors to CTL-Mediated Killing in Therapeutic Synergy
Clin. Cancer Res., January 1, 2007; 13(1): 341 - 349.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. N. Kochenderfer, C. D. Chien, J. L. Simpson, and R. E. Gress
Synergism between CpG-Containing Oligodeoxynucleotides and IL-2 Causes Dramatic Enhancement of Vaccine-Elicited CD8+ T Cell Responses
J. Immunol., December 15, 2006; 177(12): 8860 - 8873.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Schirmbeck, P. Riedl, M. Kupferschmitt, U. Wegenka, H. Hauser, J. Rice, A. Kroger, and J. Reimann
Priming Protective CD8 T Cell Immunity by DNA Vaccines Encoding Chimeric, Stress Protein-Capturing Tumor-Associated Antigen
J. Immunol., August 1, 2006; 177(3): 1534 - 1542.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W.-P. Woo, T. Doan, K. A. Herd, H.-J. Netter, and R. W. Tindle
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
J. Virol., April 1, 2006; 80(8): 3975 - 3984.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
K. B. Gendron, A. Rodriguez, and D. A. Sewell
Vaccination with human papillomavirus type 16 e7 Peptide with CpG oligonucleotides for prevention of tumor growth in mice.
Arch Otolaryngol Head Neck Surg, March 1, 2006; 132(3): 327 - 332.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. R. Haas, J. Sun, A. Vachani, A. F. Wallace, M. Silverberg, V. Kapoor, and S. M. Albelda
Cycloxygenase-2 Inhibition Augments the Efficacy of a Cancer Vaccine
Clin. Cancer Res., January 1, 2006; 12(1): 214 - 222.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Lee, M. Fassnacht, S. Nair, D. Boczkowski, and E. Gilboa
Tumor Immunotherapy Targeting Fibroblast Activation Protein, a Product Expressed in Tumor-Associated Fibroblasts
Cancer Res., December 1, 2005; 65(23): 11156 - 11163.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. G. Bermudez-Humaran, N. G. Cortes-Perez, F. Lefevre, V. Guimaraes, S. Rabot, J. M. Alcocer-Gonzalez, J.-J. Gratadoux, C. Rodriguez-Padilla, R. S. Tamez-Guerra, G. Corthier, et al.
A Novel Mucosal Vaccine Based on Live Lactococci Expressing E7 Antigen and IL-12 Induces Systemic and Mucosal Immune Responses and Protects Mice against Human Papillomavirus Type 16-Induced Tumors
J. Immunol., December 1, 2005; 175(11): 7297 - 7302.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Acres, M. Gantzer, C. Remy, N. Futin, N. Accart, O. Chaloin, J. Hoebeke, J.-M. Balloul, and S. Paul
Fusokine Interleukin-2/Interleukin-18, a Novel Potent Innate and Adaptive Immune Stimulator with Decreased Toxicity
Cancer Res., October 15, 2005; 65(20): 9536 - 9546.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-W. Liao, C.-A. Chen, C.-N. Lee, Y.-N. Su, M.-C. Chang, M.-H. Syu, C.-Y. Hsieh, and W.-F. Cheng
Fusion Protein Vaccine by Domains of Bacterial Exotoxin Linked with a Tumor Antigen Generates Potent Immunologic Responses and Antitumor Effects
Cancer Res., October 1, 2005; 65(19): 9089 - 9098.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Suzuki, V. Kapoor, A. S. Jassar, L. R. Kaiser, and S. M. Albelda
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
Clin. Cancer Res., September 15, 2005; 11(18): 6713 - 6721.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Muraro, A. Bondanza, M. Bellone, P. D. Greenberg, and C. Bonini
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responses
Blood, May 1, 2005; 105(9): 3596 - 3604.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Su, J. Dannull, B. K. Yang, P. Dahm, D. Coleman, D. Yancey, S. Sichi, D. Niedzwiecki, D. Boczkowski, E. Gilboa, et al.
Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer
J. Immunol., March 15, 2005; 174(6): 3798 - 3807.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Preville, D. Ladant, B. Timmerman, and C. Leclerc
Eradication of Established Tumors by Vaccination With Recombinant Bordetella pertussis Adenylate Cyclase Carrying the Human Papillomavirus 16 E7 Oncoprotein
Cancer Res., January 15, 2005; 65(2): 641 - 649.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. W. Kim, J.-H. Lee, L. He, D. A.K. Boyd, J. M. Hardwick, C.-F. Hung, and T-C. Wu
Modification of Professional Antigen-Presenting Cells with Small Interfering RNA In vivo to Enhance Cancer Vaccine Potency
Cancer Res., January 1, 2005; 65(1): 309 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. A. Sewell, V. Shahabi, G. R. Gunn III, Z.-K. Pan, M. E. Dominiecki, and Y. Paterson
Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
Cancer Res., December 15, 2004; 64(24): 8821 - 8825.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Verch, Z.-K. Pan, and Y. Paterson
Listeria monocytogenes-Based Antibiotic Resistance Gene-Free Antigen Delivery System Applicable to Other Bacterial Vectors and DNA Vaccines
Infect. Immun., November 1, 2004; 72(11): 6418 - 6425.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Liu, B. Acres, J.-M. Balloul, N. Bizouarne, S. Paul, P. Slos, and P. Squiban
Gene-based vaccines and immunotherapeutics
PNAS, October 5, 2004; 101(suppl_2): 14567 - 14571.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Peng, H. Ji, C. Trimble, L. He, Y.-C. Tsai, J. Yeatermeyer, D. A. K. Boyd, C.-F. Hung, and T.-C. Wu
Development of a DNA Vaccine Targeting Human Papillomavirus Type 16 Oncoprotein E6
J. Virol., August 15, 2004; 78(16): 8468 - 8476.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Peng, S. F. Hussain, and Y. Paterson
The Ability of Two Listeria monocytogenes Vaccines Targeting Human Papillomavirus-16 E7 to Induce an Antitumor Response Correlates with Myeloid Dendritic Cell Function
J. Immunol., May 15, 2004; 172(10): 6030 - 6038.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y.-F. Chen, C.-W. Lin, Y.-P. Tsao, and S.-L. Chen
Cytotoxic-T-Lymphocyte Human Papillomavirus Type 16 E5 Peptide with CpG-Oligodeoxynucleotide Can Eliminate Tumor Growth in C57BL/6 Mice
J. Virol., February 1, 2004; 78(3): 1333 - 1343.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. W. Kim, C.-F. Hung, D. A. K. Boyd, L. He, C.-T. Lin, D. Kaiserman, P. I. Bird, and T-C. Wu
Enhancement of DNA Vaccine Potency by Coadministration of a Tumor Antigen Gene and DNA Encoding Serine Protease Inhibitor-6
Cancer Res., January 1, 2004; 64(1): 400 - 405.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
D. A. Sewell, D. Douven, Z.-K. Pan, A. Rodriguez, and Y. Paterson
Regression of HPV-Positive Tumors Treated With a New Listeria monocytogenes Vaccine
Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 92 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Zhang, Y. Tang, H. Akbulut, D. Zelterman, P.-J. Linton, and A. B. Deisseroth
An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells
PNAS, December 9, 2003; 100(25): 15101 - 15106.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. H. Manjili, X.-Y. Wang, X. Chen, T. Martin, E. A. Repasky, R. Henderson, and J. R. Subjeck
HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice
J. Immunol., October 15, 2003; 171(8): 4054 - 4061.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. T. A. Marques Jr., P. Chikhlikar, L. B. de Arruda, I. C. Leao, Y. Lu, J. Wong, J.-S. Chen, B. Byrne, and J. T. August
HIV-1 p55Gag Encoded in the Lysosome-associated Membrane Protein-1 as a DNA Plasmid Vaccine Chimera Is Highly Expressed, Traffics to the Major Histocompatibility Class II Compartment, and Elicits Enhanced Immune Responses
J. Biol. Chem., September 26, 2003; 278(39): 37926 - 37936.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. W. Kim, C.-F. Hung, D. Boyd, J. Juang, L. He, J. W. Kim, J. M. Hardwick, and T.-C. Wu
Enhancing DNA Vaccine Potency by Combining a Strategy to Prolong Dendritic Cell Life with Intracellular Targeting Strategies
J. Immunol., September 15, 2003; 171(6): 2970 - 2976.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
K. Devaraj, M. L. Gillison, and T.-C. Wu
DEVELOPMENT OF HPV VACCINES FOR HPV-ASSOCIATED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Critical Reviews in Oral Biology & Medicine, September 1, 2003; 14(5): 345 - 362.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. J. Stewart, M. J. Smyth, G. J. P. Fernando, I. H. Frazer, and G. R. Leggatt
Inhibition of Early Tumor Growth Requires J{alpha}18-positive (Natural Killer T) Cells
Cancer Res., June 15, 2003; 63(12): 3058 - 3060.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-F. Hung, W.-F. Cheng, L. He, M. Ling, J. Juang, C.-T. Lin, and T-C. Wu
Enhancing Major Histocompatibility Complex Class I Antigen Presentation by Targeting Antigen to Centrosomes
Cancer Res., May 15, 2003; 63(10): 2393 - 2398.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T.-Y. Kim, H.-J. Myoung, J.-H. Kim, I.-S. Moon, T.-G. Kim, W.-S. Ahn, and J.-I. Sin
Both E7 and CpG-Oligodeoxynucleotide Are Required for Protective Immunity against Challenge with Human Papillomavirus 16 (E6/E7) Immortalized Tumor Cells: Involvement of CD4+ and CD8+ T Cells in Protection
Cancer Res., December 15, 2002; 62(24): 7234 - 7240.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Li, Y. Sun, and A. Garen
Immunization and immunotherapy for cancers involving infection by a human papillomavirus in a mouse model
PNAS, December 10, 2002; 99(25): 16232 - 16236.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. M. Kaufmann, P. L. Stern, E. M. Rankin, H. Sommer, V. Nuessler, A. Schneider, M. Adams, T. S. Onon, T. Bauknecht, U. Wagner, et al.
Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer
Clin. Cancer Res., December 1, 2002; 8(12): 3676 - 3685.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. L. Eiben, M. P. Velders, H. Schreiber, M. C. Cassetti, J. K. Pullen, L. R. Smith, and W. M. Kast
Establishment of an HLA-A*0201 Human Papillomavirus Type 16 Tumor Model to Determine the Efficacy of Vaccination Strategies in HLA-A*0201 Transgenic Mice
Cancer Res., October 15, 2002; 62(20): 5792 - 5799.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
M. A. Steller
Cervical Cancer Vaccines: Progress and Prospects
Reproductive Sciences, September 1, 2002; 9(5): 254 - 264.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
Z. Su, J. Vieweg, A. Z. Weizer, P. Dahm, D. Yancey, V. Turaga, J. Higgins, D. Boczkowski, E. Gilboa, and J. Dannull
Enhanced Induction of Telomerase-specific CD4+ T Cells Using Dendritic Cells Transfected with RNA Encoding a Chimeric Gene Product
Cancer Res., September 1, 2002; 62(17): 5041 - 5048.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Zwaveling, S. C. F. Mota, J. Nouta, M. Johnson, G. B. Lipford, R. Offringa, S. H. van der Burg, and C. J. M. Melief
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
J. Immunol., July 1, 2002; 169(1): 350 - 358.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. C. Wolkers, M. Toebes, M. Okabe, J. B. A. G. Haanen, and T. N. M. Schumacher
Optimizing the Efficacy of Epitope-Directed DNA Vaccination
J. Immunol., May 15, 2002; 168(10): 4998 - 5004.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. H. Manjili, R. Henderson, X.-Y. Wang, X. Chen, Y. Li, E. Repasky, L. Kazim, and J. R. Subjeck
Development of a Recombinant HSP110-HER-2/neu Vaccine Using the Chaperoning Properties of HSP110
Cancer Res., March 1, 2002; 62(6): 1737 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C.-F. Hung, L. He, J. Juang, T.-J. Lin, M. Ling, and T.-C. Wu
Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen
J. Virol., February 22, 2002; 76(6): 2676 - 2682.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. R. Gunn, A. Zubair, C. Peters, Z.-K. Pan, T.-C. Wu, and Y. Paterson
Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16
J. Immunol., December 1, 2001; 167(11): 6471 - 6479.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
F. Rodriguez, S. Harkins, J. M. Redwine, J. M. de Pereda, and J. L. Whitton
CD4+ T Cells Induced by a DNA Vaccine: Immunological Consequences of Epitope-Specific Lysosomal Targeting
J. Virol., November 1, 2001; 75(21): 10421 - 10430.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. P. Velders, S. McElhiney, M. C. Cassetti, G. L. Eiben, T. Higgins, G. R. Kovacs, A. G. Elmishad, W. M. Kast, and L. R. Smith
Eradication of Established Tumors by Vaccination with Venezuelan Equine Encephalitis Virus Replicon Particles Delivering Human Papillomavirus 16 E7 RNA
Cancer Res., November 1, 2001; 61(21): 7861 - 7867.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Lamikanra, Z.-K. Pan, S. N. Isaacs, T.-C. Wu, and Y. Paterson
Regression of Established Human Papillomavirus Type 16 (HPV-16) Immortalized Tumors In Vivo by Vaccinia Viruses Expressing Different Forms of HPV-16 E7 Correlates with Enhanced CD8+ T-Cell Responses That Home to the Tumor Site
J. Virol., October 15, 2001; 75(20): 9654 - 9664.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. W. Tindle, K. Herd, T. Doan, G. Bryson, G. R. Leggatt, P. Lambert, I. H. Frazer, and M. Street
Nonspecific Down-Regulation of CD8+ T-Cell Responses in Mice Expressing Human Papillomavirus Type 16 E7 Oncoprotein from the Keratin-14 Promoter
J. Virol., July 1, 2001; 75(13): 5985 - 5997.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. D. Heller, J. Kuo, T. C. Wu, W. M. Kast, and R. C. C. Huang
Tetra-O-methyl Nordihydroguaiaretic Acid Induces G2 Arrest in Mammalian Cells and Exhibits Tumoricidal Activity in Vivo
Cancer Res., July 1, 2001; 61(14): 5499 - 5504.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W.-F. Cheng, C.-F. Hung, C.-Y. Chai, K.-F. Hsu, L. He, C. M. Rice, M. Ling, and T.-C. Wu
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Mycobacterium tuberculosis Heat Shock Protein 70 Gene to an Antigen Gene
J. Immunol., May 15, 2001; 166(10): 6218 - 6226.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-F. Hung, W.-F. Cheng, K.-F. Hsu, C.-Y. Chai, L. He, M. Ling, and T-C. Wu
Cancer Immunotherapy Using a DNA Vaccine Encoding the Translocation Domain of a Bacterial Toxin Linked to a Tumor Antigen
Cancer Res., May 1, 2001; 61(9): 3698 - 3703.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
C.-F. Hung, W.-F. Cheng, C.-Y. Chai, K.-F. Hsu, L. He, M. Ling, and T.-C. Wu
Improving Vaccine Potency Through Intercellular Spreading and Enhanced MHC Class I Presentation of Antigen
J. Immunol., May 1, 2001; 166(9): 5733 - 5740.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Bonini, S. P. Lee, S. R. Riddell, and P. D. Greenberg
Targeting Antigen in Mature Dendritic Cells for Simultaneous Stimulation of CD4+ and CD8+ T Cells
J. Immunol., April 15, 2001; 166(8): 5250 - 5257.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Wu, J.-M. Wu, A. Miagkov, R. N. Adams, H. I. Levitsky, and D. B. Drachman
Specific Immunotherapy by Genetically Engineered APCs: The ""Guided Missile"" Strategy
J. Immunol., April 1, 2001; 166(7): 4773 - 4779.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W.-F. Cheng, C.-F. Hung, C.-Y. Chai, K.-F. Hsu, L. He, M. Ling, and T.-C. Wu
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Herpes Simplex Virus Type 1 VP22 Protein to Antigen
J. Virol., March 1, 2001; 75(5): 2368 - 2376.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
C.-F. Hung, K.-F. Hsu, W.-F. Cheng, C.-Y. Chai, L. He, M. Ling, and T-C. Wu
Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to a Gene Encoding the Extracellular Domain of Fms-like Tyrosine Kinase 3-Ligand
Cancer Res., February 1, 2001; 61(3): 1080 - 1088.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. van Bergen, M. Camps, R. Offringa, C. J. M. Melief, F. Ossendorp, and F. Koning
Superior Tumor Protection Induced by a Cellular Vaccine Carrying a Tumor-specific T Helper Epitope by Genetic Exchange of the Class II-associated Invariant Chain Peptide
Cancer Res., November 1, 2000; 60(22): 6427 - 6433.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
D.-W. Liu, Y.-P. Tsao, C.-H. Hsieh, J.-T. Hsieh, J. T. Kung, C.-L. Chiang, S.-J. Huang, and S.-L. Chen
Induction of CD8 T Cells by Vaccination with Recombinant Adenovirus Expressing Human Papillomavirus Type 16 E5 Gene Reduces Tumor Growth
J. Virol., October 1, 2000; 74(19): 9083 - 9089.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. P. M. Vierboom, S. Zwaveling, G. M. J. Bos, M. Ooms, G. M. Krietemeijer, C. J. M. Melief, and R. Offringa
High Steady-State Levels of p53 Are Not a Prerequisite for Tumor Eradication by Wild-Type p53-specific Cytotoxic T Lymphocytes
Cancer Res., October 1, 2000; 60(19): 5508 - 5513.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
D.-W. Liu, Y.-P. Tsao, J. T. Kung, Y.-A. Ding, H.-K. Sytwu, X. Xiao, and S.-L. Chen
Recombinant Adeno-Associated Virus Expressing Human Papillomavirus Type 16 E7 Peptide DNA Fused with Heat Shock Protein DNA as a Potential Vaccine for Cervical Cancer
J. Virol., March 15, 2000; 74(6): 2888 - 2894.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
C.-H. Chen, T.-L. Wang, C.-F. Hung, Y. Yang, R. A. Young, D. M. Pardoll, and T-C. Wu
Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to an HSP70 Gene
Cancer Res., February 1, 2000; 60(4): 1035 - 1042.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
W. Shi, P. Bu, J. Liu, A. Polack, S. Fisher, and L. Qiao
Human Papillomavirus Type 16 E7 DNA Vaccine: Mutation in the Open Reading Frame of E7 Enhances Specific Cytotoxic T-Lymphocyte Induction and Antitumor Activity
J. Virol., September 1, 1999; 73(9): 7877 - 7881.
[Abstract] [Full Text]

Home page
 JCOHome page
T. F. Greten and E. M. Jaffee
Cancer Vaccines
J. Clin. Oncol., March 1, 1999; 17(3): 1047 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. Chaux, V. Vantomme, V. Stroobant, K. Thielemans, J. Corthals, R. Luiten, A. M.M. Eggermont, T. Boon, and P. van der Bruggen
Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes
J. Exp. Med., March 1, 1999; 189(5): 767 - 778.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. J. P. Fernando, T. J. Stewart, R. W. Tindle, and I. H. Frazer
Th2-Type CD4+ Cells Neither Enhance nor Suppress Antitumor CTL Activity in a Mouse Tumor Model
J. Immunol., September 1, 1998; 161(5): 2421 - 2427.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
D. R. Lowy and J. T. Schiller
Papillomaviruses and Cervical Cancer: Pathogenesis and Vaccine Development
J Natl Cancer Inst Monographs, April 1, 1998; 1998(23): 27 - 30.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
S. A. Thomson, S. R. Burrows, I. S. Misko, D. J. Moss, B. E. H. Coupar, and R. Khanna
Targeting a Polyepitope Protein Incorporating Multiple Class II-Restricted Viral Epitopes to the Secretory/Endocytic Pathway Facilitates Immune Recognition by CD4+ Cytotoxic T Lymphocytes: a Novel Approach to Vaccine Design
J. Virol., March 1, 1998; 72(3): 2246 - 2252.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. L. Greenstone, J. D. Nieland, K. E. de Visser, M. L. H. De Bruijn, R. Kirnbauer, R. B. S. Roden, D. R. Lowy, W. M. Kast, and J. T. Schiller
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
PNAS, February 17, 1998; 95(4): 1800 - 1805.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Tuting, C. C. Wilson, D. M. Martin, Y. L. Kasamon, J. Rowles, D. I. Ma, C. L. Slingluff Jr., S. N. Wagner, P. van der Bruggen, J. Baar, et al.
Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-{alpha}
J. Immunol., February 1, 1998; 160(3): 1139 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. Osanto
Vaccine Trials for the Clinician: Prospects for Tumor Antigens
Oncologist, October 1, 1997; 2(5): 284 - 299.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. L. Ruff, F. G. Guarnieri, K. Staveley-O'Carroll, R. F. Siliciano, and J. T. August
The Enhanced Immune Response to the HIV gp160/LAMP Chimeric Gene Product Targeted to the Lysosome Membrane Protein Trafficking Pathway
J. Biol. Chem., March 28, 1997; 272(13): 8671 - 8678.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. P. Medema, J. de Jong, L. T. C. Peltenburg, E. M. E. Verdegaal, A. Gorter, S. A. Bres, K. L. M. C. Franken, M. Hahne, J. P. Albar, C. J. M. Melief, et al.
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors
PNAS, September 25, 2001; 98(20): 11515 - 11520.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.